CPIX reports positive Phase 2a results for Ifetroban, showing a favorable safety profile and promising early signs of ...

Adjuvant approach will need confirmation from ongoing phase III trial, says expert ...

For patients with high-risk resected melanoma, adding the mRNA vaccine intismeran to pembrolizumab continued to stave off recurrence and distant metastases at 5 years.

A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that ...

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...

High-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)—plus hormone therapy before and ...

A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that implanting collagen tiles during brain surgery to deliver targeted radiation therapy ...

Breast cancer can go away for a while and then show up again. It can also spread to different areas of your body when it comes back. Sometimes, breast cancer returns and spreads to the pleura, the ...

Placing collagen tiles embedded with cesium-131 seeds into the surgical cavity when resecting brain metastases significantly ...

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...